Dr. Patel reminds New Yorkers not to neglect colorectal cancer screenings

We’ve heard many medical experts speak out during the COVID-19 pandemic, urging people to not neglect other aspects of their health because of the virus. Doctors are using the month of march to double down on that, when it comes to the problem of colorectal cancer.

MORE: New York releases list of underlying health conditions eligible for vaccine Feb. 15

March itself is National Colorectal Cancer Awareness Month, and Dr. Reena Patel of Albany Gastroenterology Consultants says this is the perfect time to remind New Yorkers of the risks, and to get screened. Dr. Patel says the biggest at-risk demographic are African-Americans and Hispanics. The doctor says people in these groups need to be screened earlier, around the age of 45.

“It depends on your family history, and any symptoms you may be presenting at. But traditionally, all patients should begin screening at the age of 50.”

Dr. Patel points out there’s been a recent change in guidelines to argue that everyone should begin screening earlier, and that’s in the process of being finalized. But the important thing to look for are small growth, or polyps. Doctor Patel says despite the pandemic, it is critical to get screened.

 
“Something that we’ve been very worried about is the rate of colon cancer is pushing about 90% in regards to this recent pandemic and COVID.”

Dr. Patel says it all comes down to what’s found in that first screening, in terms of determining how often you need to be screened again, and many facilities can incorporate telehealth visits before the screening, to limit office visits. The doctor says colon cancer is one of the only cancers that are preventable, but detection is key.

Additional News & Events

Esophageal Cancer Awareness Month

According to the American Cancer Society, esophageal cancer (EAC) makes up approximately 1% of all cancers diagnosed in the United States. EAC is considered an aggressive cancer with an overall five-year survival rate of only 19.9%.

Read More »

LiveSmart: Minimally Invasive Treatments Available in Battle against Colorectal Cancer, Pre-Cancerous Polyps

The importance of screening for colorectal cancer has become even more apparent during the COVID-19 pandemic. National preventative colorectal cancer screening rates decreased significantly compared to before COVID. While there is still much work to be done, there is hope. With increased colorectal screening and state of the art treatment, we can detect cancer at earlier and curable stages, helping patients lead longer and healthier lives.

Read More »

Follow Us

Scroll to Top